scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Zahir Amoura | Q69662859 |
Jean-Charles Piette | Q73305204 | ||
P2093 | author name string | B Wechsler | |
T Papo | |||
J-B Arlet | |||
A Marinho | |||
Thi Huong D Le | |||
P2860 | cites work | Proposal for a new set of classification criteria for adult-onset still disease | Q78069999 |
Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis | Q78874963 | ||
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome | Q24798867 | ||
Adult-onset Still disease presenting with disseminated intravascular coagulation | Q28168791 | ||
Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients | Q28191614 | ||
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders | Q28362327 | ||
Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review | Q33357155 | ||
Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. | Q33500569 | ||
Preliminary criteria for classification of adult Still's disease | Q34405573 | ||
Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities. | Q35082963 | ||
Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? | Q35213886 | ||
Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis | Q36116060 | ||
Adult Still's disease: manifestations, disease course, and outcome in 62 patients | Q37670649 | ||
Hematophagic histiocytosis. A report of 23 new patients and a review of the literature | Q39536314 | ||
Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes | Q39579621 | ||
Current concepts on the physiopathology of adult-onset Still's disease | Q40504633 | ||
Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease. | Q40512288 | ||
Hemophagocytic syndrome | Q40573018 | ||
Adult-onset Still's disease accompanied by hemophagocytic syndrome at onset | Q40585564 | ||
A case of hemophagocytic syndrome with severe liver injury manifestating adult Still's disease | Q40644635 | ||
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome | Q40663505 | ||
A case of hemophagocytic syndrome manifesting adult Still's disease and acute hepatitis | Q40687324 | ||
Usefulness of glycosylated ferritin in atypical presentations of adult onset Still's disease. | Q43049853 | ||
Etanercept in the treatment of macrophage activation syndrome. | Q43733246 | ||
Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness | Q43786181 | ||
Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome | Q43965206 | ||
Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy | Q44924027 | ||
Intravenous immunoglobulin in adult Still's disease refractory to non-steroidal anti-inflammatory drugs. | Q47958008 | ||
Adult-onset Still's disease with respiratory distress syndrome, polyserositis and disseminated intravascular coagulation: a case with a fatal outcome. | Q51679145 | ||
High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation | Q58621869 | ||
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society | Q68192027 | ||
Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation | Q73023710 | ||
Bone marrow findings in patients with adult Still's disease | Q73369652 | ||
Adult onset Still's disease with hemophagocytic syndrome and severe liver dysfunction | Q73521233 | ||
Adult onset Still's disease associated hemophagocytosis | Q73601289 | ||
Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease | Q73608471 | ||
[Hyperferritinemia in Still syndrome in the adult and reactive hemophagocytic syndrome] | Q73811914 | ||
The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus | Q77403505 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adult-onset Still's disease | Q1187697 |
P304 | page(s) | 1596-1601 | |
P577 | publication date | 2006-03-15 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature | |
P478 | volume | 65 |
Q33390915 | A long story begun with a simple sore throat |
Q42333588 | About the complexity of adult onset Still's disease… and advances still required for its management |
Q37402329 | Adult Onset Still's Disease Associated with Mycoplasma pneumoniae Infection and Hemophagocytic Lymphohistiocytosis. |
Q37506778 | Adult Onset Still's Disease Presenting with Acute Respiratory Distress Syndrome: Case Report and Review of the Literature. |
Q36220940 | Adult Onset Still's Disease and Autoinflammation |
Q40412222 | Adult onset Still's disease |
Q40263834 | Adult onset Still's disease: experience from a tertiary care rheumatology unit. |
Q56529255 | Adult-Onset Still's Disease and Macrophage-Activating Syndrome Progressing to Lymphoma: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery |
Q39366004 | Adult-onset Still disease: a rare disorder with a potentially fatal outcome |
Q26852631 | Adult-onset Still's disease |
Q40367272 | Adult-onset Still's disease complicated with hemophagocytic syndrome. |
Q42265969 | Adult-onset Still's disease revealed by perimyocarditis and a concomitant reactivation of an EBV infection |
Q51450723 | Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept. |
Q28079446 | Adult-onset Still's disease: current challenges and future prospects |
Q36208563 | Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers |
Q37079113 | Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances |
Q33414045 | Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients |
Q38637780 | Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? |
Q38059457 | Anaemia in inflammatory rheumatic diseases |
Q90550872 | Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease? |
Q56448781 | Atteinte hépatique dans les maladies de système |
Q51545663 | Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome |
Q33429509 | Clinical characteristics and follow-up analysis of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis |
Q36318120 | Clinical features and prognosis of adult-onset Still's disease: 75 cases from China |
Q53395475 | Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. |
Q44529451 | Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases |
Q48676273 | Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis |
Q55109011 | Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review. |
Q33594698 | Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease |
Q40630580 | Epidemiological study of adult-onset Still's disease using a Japanese administrative database |
Q47156287 | Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome. |
Q38005702 | Ferritin in adult-onset still's disease: just a useful innocent bystander? |
Q40451748 | Fever, nephrotic syndrome, and rapidly progressive renal failure. |
Q24652615 | Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis |
Q33414047 | Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients |
Q37728923 | Hemophagocytic syndrome in adult-onset Still's disease (AOSD): a must for biologics?--Case report and brief review of the literature |
Q34553515 | Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease |
Q36165878 | Hepatic tuberculosis presenting with extreme hyperferritinemia masquerading as adult-onset Still's disease: a case report |
Q40308274 | Leukocytapheresis (LCAP) for treating refractory adult-onset Still's disease (AOSD). |
Q33412732 | Life-threatening complications of adult-onset Still's disease |
Q40081000 | Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra. |
Q40183555 | Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan |
Q34042413 | Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart. |
Q26830024 | Pathophysiology, subtypes, and treatments of adult-onset Still's disease: An update |
Q37177936 | Pure Red Cell Aplasia with Adult Onset Still's Disease |
Q33751485 | Quotidian High Spiking Fevers in Adult Still's Disease. |
Q33420069 | Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients |
Q47160193 | Refractory Adult Onset Still’s Disease |
Q46210307 | Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease |
Q94565447 | Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome |
Q37263772 | Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease: A Case-Based Review |
Q89942798 | Successful treatment of adult-onset still disease caused by pulmonary infection-associated hemophagocytic lymphohistiocytosis: A case report |
Q54571811 | Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis. |
Q36645748 | Ten years of clinical experience with adult onset Still's disease: is the outcome improving? |
Q38056419 | Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence |
Q34043097 | Treatment of adult-onset Still's disease: a review |
Q38679486 | Treatment of adult-onset still's disease: up to date. |
Q52969725 | Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease. |
Q37474325 | What nephrologists need to know about hemophagocytic syndrome |
Q84631018 | [Macrophage activation syndrome] |
Search more.